Parthak Prodhan
Concepts (426)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Extracorporeal Membrane Oxygenation | 32 | 2021 | 302 | 7.590 |
Why?
| Hypoplastic Left Heart Syndrome | 5 | 2018 | 97 | 2.800 |
Why?
| Infant | 55 | 2021 | 3817 | 2.400 |
Why?
| Norwood Procedures | 5 | 2022 | 57 | 2.380 |
Why?
| Infant, Newborn | 47 | 2022 | 2907 | 2.280 |
Why?
| Hospital Mortality | 17 | 2022 | 465 | 2.230 |
Why?
| Heart-Assist Devices | 8 | 2016 | 147 | 2.090 |
Why?
| Palliative Care | 6 | 2020 | 188 | 1.970 |
Why?
| Respiration, Artificial | 8 | 2015 | 285 | 1.880 |
Why?
| Child, Preschool | 46 | 2021 | 4147 | 1.810 |
Why?
| Heart Diseases | 7 | 2021 | 237 | 1.780 |
Why?
| Retrospective Studies | 50 | 2022 | 6432 | 1.760 |
Why?
| Heart Defects, Congenital | 9 | 2015 | 608 | 1.610 |
Why?
| Child | 53 | 2022 | 7341 | 1.600 |
Why?
| Hemolytic-Uremic Syndrome | 2 | 2021 | 17 | 1.560 |
Why?
| Heart Failure | 6 | 2022 | 541 | 1.520 |
Why?
| Cardiopulmonary Resuscitation | 5 | 2019 | 137 | 1.480 |
Why?
| Heart Transplantation | 9 | 2018 | 307 | 1.460 |
Why?
| Tetralogy of Fallot | 7 | 2021 | 94 | 1.360 |
Why?
| Male | 65 | 2021 | 27334 | 1.310 |
Why?
| Registries | 10 | 2019 | 553 | 1.250 |
Why?
| Humans | 98 | 2022 | 54284 | 1.240 |
Why?
| Female | 67 | 2021 | 28441 | 1.220 |
Why?
| Intensive Care Units, Pediatric | 9 | 2022 | 186 | 1.170 |
Why?
| Terminal Care | 2 | 2020 | 56 | 1.120 |
Why?
| Cardiac Surgical Procedures | 9 | 2022 | 318 | 1.090 |
Why?
| Adolescent | 29 | 2021 | 6897 | 1.030 |
Why?
| Risk Factors | 20 | 2021 | 3935 | 0.970 |
Why?
| Down Syndrome | 4 | 2021 | 100 | 0.930 |
Why?
| Cohort Studies | 10 | 2021 | 1543 | 0.900 |
Why?
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 55 | 0.820 |
Why?
| Treatment Outcome | 23 | 2021 | 5604 | 0.810 |
Why?
| Length of Stay | 11 | 2021 | 683 | 0.790 |
Why?
| Respiratory Insufficiency | 3 | 2014 | 127 | 0.790 |
Why?
| Pulmonary Artery | 1 | 2022 | 151 | 0.780 |
Why?
| Heart Arrest | 4 | 2022 | 159 | 0.750 |
Why?
| Brain Diseases | 1 | 2021 | 87 | 0.740 |
Why?
| Hospice Care | 1 | 2020 | 27 | 0.730 |
Why?
| Patient Transfer | 5 | 2015 | 103 | 0.720 |
Why?
| American Heart Association | 1 | 2019 | 36 | 0.720 |
Why?
| Gastrostomy | 3 | 2020 | 60 | 0.720 |
Why?
| Monitoring, Physiologic | 3 | 2016 | 136 | 0.710 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 2014 | 53 | 0.700 |
Why?
| Critical Care | 5 | 2020 | 234 | 0.700 |
Why?
| Respiratory Syncytial Virus Infections | 2 | 2010 | 37 | 0.690 |
Why?
| Cardiopulmonary Bypass | 5 | 2013 | 97 | 0.680 |
Why?
| Home Care Services | 1 | 2020 | 79 | 0.680 |
Why?
| Critical Illness | 7 | 2022 | 344 | 0.660 |
Why?
| Follow-Up Studies | 10 | 2018 | 2387 | 0.650 |
Why?
| Oxygen | 3 | 2014 | 361 | 0.640 |
Why?
| Enteral Nutrition | 2 | 2018 | 136 | 0.630 |
Why?
| Tracheostomy | 3 | 2020 | 81 | 0.630 |
Why?
| Enterocolitis, Necrotizing | 1 | 2018 | 36 | 0.620 |
Why?
| Hospitalization | 8 | 2022 | 705 | 0.610 |
Why?
| Heart Bypass, Right | 1 | 2017 | 7 | 0.600 |
Why?
| Chromosome Disorders | 1 | 2017 | 39 | 0.600 |
Why?
| Adenovirus Infections, Human | 2 | 2014 | 8 | 0.590 |
Why?
| Time Factors | 14 | 2021 | 3213 | 0.570 |
Why?
| Patient Discharge | 4 | 2013 | 353 | 0.550 |
Why?
| Adrenal Cortex Hormones | 2 | 2015 | 95 | 0.550 |
Why?
| Pressure | 1 | 2016 | 120 | 0.540 |
Why?
| Airway Extubation | 2 | 2012 | 38 | 0.530 |
Why?
| Shock, Septic | 3 | 2011 | 80 | 0.520 |
Why?
| Chromosomes, Human, Pair 22 | 1 | 2015 | 42 | 0.520 |
Why?
| Acute-Phase Proteins | 1 | 2015 | 25 | 0.520 |
Why?
| Transportation of Patients | 2 | 2012 | 39 | 0.520 |
Why?
| Stenotrophomonas maltophilia | 1 | 2014 | 6 | 0.510 |
Why?
| Databases, Factual | 5 | 2018 | 684 | 0.500 |
Why?
| Gram-Negative Bacterial Infections | 1 | 2014 | 42 | 0.490 |
Why?
| von Willebrand Diseases | 1 | 2014 | 21 | 0.490 |
Why?
| Intensive Care Units, Neonatal | 2 | 2012 | 117 | 0.490 |
Why?
| von Willebrand Factor | 1 | 2014 | 53 | 0.490 |
Why?
| Chromosome Deletion | 1 | 2015 | 150 | 0.490 |
Why?
| Respiratory Tract Fistula | 1 | 2013 | 2 | 0.480 |
Why?
| Postoperative Hemorrhage | 1 | 2014 | 53 | 0.480 |
Why?
| Bronchial Fistula | 1 | 2013 | 5 | 0.480 |
Why?
| Sulfones | 1 | 2013 | 24 | 0.480 |
Why?
| Phosphodiesterase 5 Inhibitors | 1 | 2013 | 8 | 0.480 |
Why?
| Pleural Diseases | 1 | 2013 | 14 | 0.470 |
Why?
| Catheters | 2 | 2013 | 33 | 0.470 |
Why?
| Off-Label Use | 1 | 2013 | 27 | 0.470 |
Why?
| Drug Utilization | 1 | 2013 | 74 | 0.460 |
Why?
| Survival Rate | 6 | 2018 | 951 | 0.460 |
Why?
| Oxygen Consumption | 2 | 2012 | 223 | 0.460 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 22 | 0.450 |
Why?
| Cause of Death | 1 | 2014 | 165 | 0.450 |
Why?
| Pneumothorax | 1 | 2013 | 21 | 0.440 |
Why?
| Air Ambulances | 2 | 2012 | 27 | 0.440 |
Why?
| Piperazines | 1 | 2013 | 116 | 0.440 |
Why?
| Coronary Care Units | 1 | 2012 | 8 | 0.440 |
Why?
| Positive-Pressure Respiration | 1 | 2013 | 61 | 0.430 |
Why?
| Altitude | 1 | 2012 | 17 | 0.430 |
Why?
| Intra-Abdominal Hypertension | 1 | 2012 | 8 | 0.430 |
Why?
| Hemodynamics | 2 | 2011 | 290 | 0.430 |
Why?
| Jugular Veins | 1 | 2012 | 35 | 0.420 |
Why?
| Femoral Vein | 1 | 2012 | 45 | 0.420 |
Why?
| Postoperative Complications | 5 | 2022 | 1033 | 0.420 |
Why?
| Carotid Arteries | 1 | 2012 | 82 | 0.420 |
Why?
| Renal Artery | 1 | 2012 | 40 | 0.420 |
Why?
| Hepatitis C, Chronic | 1 | 2013 | 89 | 0.420 |
Why?
| Heart Block | 1 | 2012 | 25 | 0.420 |
Why?
| Hepacivirus | 1 | 2013 | 127 | 0.420 |
Why?
| Career Choice | 1 | 2013 | 116 | 0.420 |
Why?
| Hypertension, Pulmonary | 1 | 2013 | 126 | 0.410 |
Why?
| Emergencies | 1 | 2012 | 92 | 0.410 |
Why?
| Sepsis | 2 | 2018 | 251 | 0.410 |
Why?
| Renal Circulation | 1 | 2012 | 82 | 0.410 |
Why?
| Echocardiography, Doppler | 1 | 2012 | 61 | 0.410 |
Why?
| Continuity of Patient Care | 1 | 2012 | 64 | 0.410 |
Why?
| Radiography, Thoracic | 3 | 2011 | 69 | 0.410 |
Why?
| Echocardiography, Transesophageal | 1 | 2012 | 73 | 0.410 |
Why?
| Abnormalities, Multiple | 1 | 2013 | 159 | 0.400 |
Why?
| Neutropenia | 1 | 2012 | 120 | 0.400 |
Why?
| Kidney Failure, Chronic | 1 | 2013 | 231 | 0.390 |
Why?
| Arrhythmias, Cardiac | 1 | 2012 | 98 | 0.390 |
Why?
| Intensive Care Units | 4 | 2014 | 231 | 0.390 |
Why?
| DiGeorge Syndrome | 2 | 2021 | 20 | 0.390 |
Why?
| Femoral Artery | 1 | 2012 | 122 | 0.390 |
Why?
| Arkansas | 8 | 2012 | 2100 | 0.390 |
Why?
| Adrenal Insufficiency | 1 | 2010 | 17 | 0.380 |
Why?
| Herpesviridae Infections | 1 | 2010 | 46 | 0.370 |
Why?
| Quality of Health Care | 1 | 2012 | 222 | 0.370 |
Why?
| Survival Analysis | 5 | 2017 | 735 | 0.370 |
Why?
| Young Adult | 9 | 2017 | 4318 | 0.350 |
Why?
| Expectorants | 1 | 2009 | 14 | 0.350 |
Why?
| Respiratory Sounds | 2 | 2011 | 54 | 0.350 |
Why?
| Pulmonary Atelectasis | 1 | 2009 | 12 | 0.350 |
Why?
| Blood Specimen Collection | 1 | 2009 | 39 | 0.350 |
Why?
| Troponin I | 1 | 2009 | 20 | 0.350 |
Why?
| Deoxyribonucleases | 1 | 2009 | 24 | 0.350 |
Why?
| Thoracic Injuries | 2 | 2013 | 35 | 0.340 |
Why?
| Diagnostic Techniques, Respiratory System | 1 | 2008 | 1 | 0.340 |
Why?
| Wounds and Injuries | 1 | 2012 | 321 | 0.340 |
Why?
| Therapy, Computer-Assisted | 1 | 2008 | 34 | 0.330 |
Why?
| Cardiac Catheterization | 4 | 2019 | 258 | 0.330 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2008 | 55 | 0.330 |
Why?
| Anti-Bacterial Agents | 1 | 2014 | 820 | 0.320 |
Why?
| Prospective Studies | 7 | 2022 | 2604 | 0.320 |
Why?
| Respiratory Therapy | 1 | 2008 | 38 | 0.320 |
Why?
| Kidney | 1 | 2013 | 820 | 0.320 |
Why?
| Nurses | 1 | 2008 | 52 | 0.320 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2008 | 119 | 0.310 |
Why?
| Acute Kidney Injury | 1 | 2012 | 403 | 0.310 |
Why?
| Compartment Syndromes | 2 | 2007 | 18 | 0.310 |
Why?
| Decision Making | 1 | 2010 | 290 | 0.300 |
Why?
| Risk Assessment | 5 | 2017 | 1361 | 0.300 |
Why?
| Internship and Residency | 1 | 2013 | 501 | 0.300 |
Why?
| Prognosis | 5 | 2012 | 2118 | 0.280 |
Why?
| Hospitals, Pediatric | 5 | 2015 | 272 | 0.270 |
Why?
| Case-Control Studies | 4 | 2019 | 1228 | 0.260 |
Why?
| Brain | 3 | 2012 | 1387 | 0.260 |
Why?
| Noninvasive Ventilation | 2 | 2017 | 24 | 0.260 |
Why?
| Physicians | 1 | 2008 | 247 | 0.260 |
Why?
| Heparin | 3 | 2014 | 97 | 0.260 |
Why?
| United States | 6 | 2019 | 5217 | 0.250 |
Why?
| Algorithms | 1 | 2008 | 697 | 0.250 |
Why?
| Schistosomiasis haematobia | 1 | 2004 | 2 | 0.250 |
Why?
| Urinary Bladder Diseases | 1 | 2004 | 19 | 0.240 |
Why?
| Hematuria | 1 | 2004 | 24 | 0.240 |
Why?
| Chylothorax | 2 | 2022 | 16 | 0.240 |
Why?
| Mitral Valve Insufficiency | 2 | 2015 | 63 | 0.240 |
Why?
| Logistic Models | 5 | 2021 | 995 | 0.240 |
Why?
| Odds Ratio | 4 | 2021 | 604 | 0.240 |
Why?
| Kaplan-Meier Estimate | 3 | 2019 | 514 | 0.230 |
Why?
| Retinal Hemorrhage | 1 | 2003 | 16 | 0.230 |
Why?
| Asphyxia | 1 | 2003 | 11 | 0.230 |
Why?
| Orbital Diseases | 1 | 2003 | 13 | 0.230 |
Why?
| Encephalocele | 1 | 2003 | 15 | 0.230 |
Why?
| Severity of Illness Index | 5 | 2021 | 1084 | 0.230 |
Why?
| Syndrome | 2 | 2015 | 252 | 0.230 |
Why?
| Neck Injuries | 1 | 2003 | 26 | 0.230 |
Why?
| ROC Curve | 4 | 2012 | 259 | 0.230 |
Why?
| Water-Electrolyte Imbalance | 1 | 2022 | 17 | 0.220 |
Why?
| Anticoagulants | 3 | 2014 | 270 | 0.220 |
Why?
| Accidents, Traffic | 1 | 2003 | 117 | 0.210 |
Why?
| Reoperation | 3 | 2014 | 454 | 0.210 |
Why?
| Program Evaluation | 3 | 2018 | 374 | 0.210 |
Why?
| Pilot Projects | 3 | 2014 | 808 | 0.210 |
Why?
| Incidence | 3 | 2014 | 1082 | 0.210 |
Why?
| Neoplasms | 1 | 2012 | 1316 | 0.200 |
Why?
| Pediatrics | 2 | 2008 | 323 | 0.200 |
Why?
| Hypoxia, Brain | 1 | 2021 | 15 | 0.200 |
Why?
| North America | 1 | 2021 | 68 | 0.200 |
Why?
| Reproducibility of Results | 3 | 2010 | 1304 | 0.200 |
Why?
| Health Information Systems | 1 | 2021 | 20 | 0.200 |
Why?
| Delivery of Health Care | 1 | 2004 | 327 | 0.190 |
Why?
| Cerebrovascular Circulation | 3 | 2014 | 137 | 0.190 |
Why?
| Cerebral Infarction | 1 | 2021 | 32 | 0.190 |
Why?
| Heart Septal Defects, Atrial | 2 | 2012 | 45 | 0.190 |
Why?
| Gestational Age | 2 | 2013 | 435 | 0.190 |
Why?
| Body Weight | 2 | 2014 | 578 | 0.190 |
Why?
| Aortic Coarctation | 1 | 2021 | 32 | 0.190 |
Why?
| Confidence Intervals | 1 | 2021 | 167 | 0.190 |
Why?
| Brain Edema | 1 | 2021 | 39 | 0.190 |
Why?
| Terminally Ill | 1 | 2020 | 16 | 0.190 |
Why?
| Catheter-Related Infections | 1 | 2020 | 55 | 0.180 |
Why?
| Cerebral Hemorrhage | 1 | 2021 | 102 | 0.180 |
Why?
| Central Venous Catheters | 1 | 2020 | 31 | 0.180 |
Why?
| Spectroscopy, Near-Infrared | 4 | 2014 | 62 | 0.180 |
Why?
| Postoperative Period | 5 | 2022 | 189 | 0.180 |
Why?
| Predictive Value of Tests | 3 | 2012 | 1048 | 0.180 |
Why?
| Platelet Membrane Glycoproteins | 1 | 2018 | 25 | 0.170 |
Why?
| Catheterization, Central Venous | 1 | 2020 | 98 | 0.170 |
Why?
| Cell-Derived Microparticles | 1 | 2018 | 21 | 0.170 |
Why?
| C-Reactive Protein | 3 | 2015 | 159 | 0.170 |
Why?
| Haplotypes | 1 | 2018 | 105 | 0.160 |
Why?
| Aged, 80 and over | 3 | 2017 | 3431 | 0.160 |
Why?
| Birth Weight | 1 | 2018 | 126 | 0.150 |
Why?
| Infant Mortality | 1 | 2018 | 70 | 0.150 |
Why?
| Perioperative Care | 1 | 2017 | 42 | 0.150 |
Why?
| Academic Medical Centers | 1 | 2018 | 141 | 0.150 |
Why?
| Hospitals | 3 | 2022 | 188 | 0.150 |
Why?
| Faculty, Medical | 1 | 2018 | 100 | 0.150 |
Why?
| Shock, Cardiogenic | 1 | 2017 | 29 | 0.150 |
Why?
| Whole Blood Coagulation Time | 2 | 2014 | 6 | 0.150 |
Why?
| Waiting Lists | 1 | 2016 | 49 | 0.140 |
Why?
| Blood Platelets | 1 | 2018 | 269 | 0.140 |
Why?
| Inflammation | 3 | 2012 | 674 | 0.140 |
Why?
| Ultrasonography | 2 | 2022 | 480 | 0.140 |
Why?
| Chromosome Aberrations | 1 | 2017 | 316 | 0.130 |
Why?
| Cardiomyopathy, Dilated | 1 | 2015 | 41 | 0.130 |
Why?
| Lung | 3 | 2022 | 507 | 0.130 |
Why?
| Drug Administration Schedule | 3 | 2012 | 401 | 0.130 |
Why?
| Fibrinogen | 1 | 2015 | 37 | 0.130 |
Why?
| Ticarcillin | 1 | 2014 | 8 | 0.130 |
Why?
| Clavulanic Acids | 1 | 2014 | 9 | 0.130 |
Why?
| Patient Selection | 1 | 2016 | 286 | 0.130 |
Why?
| Patient Care Planning | 1 | 2015 | 79 | 0.130 |
Why?
| Resuscitation | 1 | 2015 | 83 | 0.130 |
Why?
| Nerve Growth Factors | 2 | 2005 | 32 | 0.130 |
Why?
| Heart Septal Defects | 1 | 2014 | 12 | 0.130 |
Why?
| Sternotomy | 1 | 2014 | 9 | 0.130 |
Why?
| Factor Xa | 1 | 2014 | 7 | 0.120 |
Why?
| Peritoneal Dialysis | 2 | 2012 | 37 | 0.120 |
Why?
| Erythrocyte Transfusion | 1 | 2014 | 74 | 0.120 |
Why?
| Autopsy | 1 | 2014 | 53 | 0.120 |
Why?
| Healthcare Disparities | 1 | 2017 | 271 | 0.120 |
Why?
| Antithrombin III | 1 | 2014 | 13 | 0.120 |
Why?
| Disease Progression | 2 | 2018 | 913 | 0.120 |
Why?
| Adrenal Glands | 1 | 2014 | 37 | 0.120 |
Why?
| Blood Coagulation Disorders | 1 | 2014 | 37 | 0.120 |
Why?
| Antithrombins | 1 | 2014 | 21 | 0.120 |
Why?
| Tumor Suppressor Proteins | 2 | 2005 | 141 | 0.120 |
Why?
| Purines | 1 | 2013 | 45 | 0.120 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2015 | 191 | 0.120 |
Why?
| Age Factors | 3 | 2017 | 1198 | 0.110 |
Why?
| Heparin Antagonists | 1 | 2013 | 7 | 0.110 |
Why?
| Protamines | 1 | 2013 | 9 | 0.110 |
Why?
| Hernia, Diaphragmatic | 1 | 2013 | 22 | 0.110 |
Why?
| Adult | 5 | 2022 | 14207 | 0.110 |
Why?
| Aged | 4 | 2017 | 10054 | 0.110 |
Why?
| Thrombelastography | 1 | 2013 | 28 | 0.110 |
Why?
| Interleukin-3 | 1 | 2012 | 13 | 0.110 |
Why?
| Organizational Objectives | 1 | 2012 | 36 | 0.110 |
Why?
| Altitude Sickness | 1 | 2012 | 8 | 0.110 |
Why?
| Calcitonin Gene-Related Peptide | 1 | 2012 | 24 | 0.110 |
Why?
| Aircraft | 1 | 2012 | 12 | 0.110 |
Why?
| Pulsatile Flow | 1 | 2012 | 18 | 0.110 |
Why?
| Comorbidity | 2 | 2014 | 663 | 0.110 |
Why?
| Hip | 1 | 2012 | 26 | 0.110 |
Why?
| Calcitonin | 1 | 2012 | 38 | 0.110 |
Why?
| Protein Precursors | 1 | 2012 | 47 | 0.110 |
Why?
| Professional-Family Relations | 1 | 2012 | 49 | 0.110 |
Why?
| Hemorrhage | 1 | 2014 | 208 | 0.110 |
Why?
| Models, Organizational | 1 | 2012 | 65 | 0.110 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2012 | 36 | 0.110 |
Why?
| Treatment Failure | 1 | 2012 | 139 | 0.110 |
Why?
| Interdisciplinary Communication | 1 | 2012 | 64 | 0.110 |
Why?
| Vascular Resistance | 1 | 2012 | 60 | 0.110 |
Why?
| Patient Positioning | 1 | 2012 | 35 | 0.110 |
Why?
| Premedication | 1 | 2011 | 18 | 0.110 |
Why?
| Tertiary Care Centers | 1 | 2012 | 83 | 0.110 |
Why?
| Rotation | 1 | 2012 | 76 | 0.100 |
Why?
| Fluconazole | 1 | 2011 | 35 | 0.100 |
Why?
| Interleukin-8 | 1 | 2012 | 97 | 0.100 |
Why?
| Body Height | 1 | 2012 | 76 | 0.100 |
Why?
| Regional Blood Flow | 1 | 2012 | 121 | 0.100 |
Why?
| Blood Flow Velocity | 1 | 2012 | 114 | 0.100 |
Why?
| Septal Occluder Device | 1 | 2012 | 29 | 0.100 |
Why?
| Infarction, Middle Cerebral Artery | 1 | 2011 | 44 | 0.100 |
Why?
| Hemolysis | 1 | 2011 | 32 | 0.100 |
Why?
| Ketamine | 1 | 2012 | 61 | 0.100 |
Why?
| Interleukin-10 | 1 | 2012 | 107 | 0.100 |
Why?
| Health Care Surveys | 1 | 2012 | 195 | 0.100 |
Why?
| Azygos Vein | 1 | 2011 | 12 | 0.100 |
Why?
| Combined Modality Therapy | 1 | 2013 | 692 | 0.100 |
Why?
| Tomography, X-Ray Computed | 2 | 2010 | 1213 | 0.100 |
Why?
| Thrombosis | 1 | 2014 | 243 | 0.100 |
Why?
| Aortic Stenosis, Supravalvular | 1 | 2010 | 13 | 0.100 |
Why?
| Adrenal Cortex Function Tests | 1 | 2010 | 5 | 0.100 |
Why?
| Neuroprotective Agents | 1 | 2012 | 125 | 0.100 |
Why?
| Comprehension | 1 | 2012 | 115 | 0.100 |
Why?
| Respiratory Tract Infections | 1 | 2011 | 84 | 0.100 |
Why?
| Cross Infection | 1 | 2011 | 107 | 0.100 |
Why?
| Adrenocorticotropic Hormone | 1 | 2010 | 34 | 0.100 |
Why?
| Tissue Plasminogen Activator | 1 | 2011 | 124 | 0.100 |
Why?
| Anti-Inflammatory Agents | 1 | 2012 | 175 | 0.100 |
Why?
| Feasibility Studies | 1 | 2012 | 398 | 0.100 |
Why?
| Catheterization | 2 | 2011 | 108 | 0.090 |
Why?
| Fibrinolytic Agents | 1 | 2011 | 139 | 0.090 |
Why?
| Thrombolytic Therapy | 1 | 2011 | 127 | 0.090 |
Why?
| Mycoses | 1 | 2011 | 162 | 0.090 |
Why?
| Echocardiography | 2 | 2011 | 392 | 0.090 |
Why?
| Interleukin-6 | 1 | 2012 | 315 | 0.090 |
Why?
| Boston | 1 | 2010 | 14 | 0.090 |
Why?
| Brain Injuries | 1 | 2012 | 183 | 0.090 |
Why?
| Patient Care Team | 1 | 2012 | 273 | 0.090 |
Why?
| Hydrocortisone | 1 | 2010 | 124 | 0.090 |
Why?
| Lactates | 1 | 2010 | 34 | 0.090 |
Why?
| Nutritional Support | 1 | 2010 | 35 | 0.090 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2012 | 434 | 0.090 |
Why?
| Inpatients | 1 | 2011 | 204 | 0.090 |
Why?
| Myocardial Infarction | 1 | 2014 | 427 | 0.090 |
Why?
| Regression Analysis | 4 | 2013 | 445 | 0.090 |
Why?
| Diagnosis, Differential | 2 | 2004 | 1136 | 0.090 |
Why?
| Lymphopenia | 1 | 2009 | 21 | 0.090 |
Why?
| Pulmonary Gas Exchange | 1 | 2009 | 23 | 0.090 |
Why?
| Pulmonary Ventilation | 1 | 2009 | 22 | 0.090 |
Why?
| Chronic Disease | 1 | 2012 | 614 | 0.090 |
Why?
| Heart Valve Prosthesis Implantation | 1 | 2010 | 90 | 0.090 |
Why?
| Infant, Premature | 1 | 2012 | 335 | 0.090 |
Why?
| Alanine Transaminase | 1 | 2009 | 151 | 0.090 |
Why?
| Substance Withdrawal Syndrome | 1 | 2010 | 179 | 0.090 |
Why?
| Lactic Acid | 1 | 2009 | 90 | 0.080 |
Why?
| Nutritional Status | 1 | 2010 | 158 | 0.080 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1056 | 0.080 |
Why?
| Endocarditis, Bacterial | 1 | 2009 | 44 | 0.080 |
Why?
| Antifungal Agents | 1 | 2011 | 363 | 0.080 |
Why?
| Reference Values | 1 | 2009 | 354 | 0.080 |
Why?
| Attitude of Health Personnel | 1 | 2012 | 397 | 0.080 |
Why?
| Analysis of Variance | 1 | 2010 | 635 | 0.080 |
Why?
| Neutrophils | 1 | 2009 | 154 | 0.080 |
Why?
| Sex Factors | 1 | 2010 | 767 | 0.080 |
Why?
| Stroke | 1 | 2013 | 526 | 0.080 |
Why?
| Recombinant Proteins | 1 | 2009 | 569 | 0.080 |
Why?
| Emergency Medical Services | 1 | 2008 | 126 | 0.080 |
Why?
| Age of Onset | 2 | 2018 | 117 | 0.070 |
Why?
| Pain | 1 | 2010 | 405 | 0.070 |
Why?
| Abdomen | 1 | 2007 | 83 | 0.070 |
Why?
| Oximetry | 1 | 2007 | 62 | 0.070 |
Why?
| Renal Dialysis | 2 | 2022 | 192 | 0.070 |
Why?
| Receptors, Cell Surface | 2 | 2005 | 130 | 0.070 |
Why?
| Sensitivity and Specificity | 1 | 2008 | 923 | 0.070 |
Why?
| Opioid-Related Disorders | 1 | 2010 | 367 | 0.070 |
Why?
| Leukocytes | 1 | 2005 | 85 | 0.070 |
Why?
| Cerebral Cortex | 1 | 2007 | 234 | 0.070 |
Why?
| Analgesics, Opioid | 1 | 2010 | 501 | 0.060 |
Why?
| Cell Movement | 1 | 2005 | 271 | 0.060 |
Why?
| Pulmonary Surfactants | 1 | 2004 | 18 | 0.060 |
Why?
| India | 1 | 2004 | 79 | 0.060 |
Why?
| Posture | 1 | 2004 | 80 | 0.060 |
Why?
| Vasodilator Agents | 1 | 2004 | 111 | 0.060 |
Why?
| Intracranial Pressure | 1 | 2003 | 32 | 0.060 |
Why?
| Endothelial Cells | 1 | 2005 | 294 | 0.060 |
Why?
| Drosophila Proteins | 1 | 2003 | 17 | 0.060 |
Why?
| Dialysis | 1 | 2022 | 10 | 0.060 |
Why?
| Receptors, Immunologic | 1 | 2003 | 37 | 0.060 |
Why?
| Cell Adhesion Molecules | 1 | 2003 | 87 | 0.060 |
Why?
| Sternum | 1 | 2022 | 8 | 0.060 |
Why?
| Intubation, Intratracheal | 1 | 2003 | 130 | 0.050 |
Why?
| Surgical Wound Infection | 1 | 2022 | 126 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2003 | 199 | 0.050 |
Why?
| Equipment Design | 2 | 2011 | 318 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2011 | 318 | 0.050 |
Why?
| Staff Development | 1 | 2018 | 26 | 0.040 |
Why?
| Efficiency | 1 | 2018 | 36 | 0.040 |
Why?
| Social Responsibility | 1 | 2018 | 31 | 0.040 |
Why?
| Job Satisfaction | 1 | 2018 | 40 | 0.040 |
Why?
| Genetic Association Studies | 1 | 2018 | 136 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2003 | 1138 | 0.040 |
Why?
| Burnout, Professional | 1 | 2018 | 57 | 0.040 |
Why?
| Leadership | 1 | 2018 | 114 | 0.040 |
Why?
| Self Efficacy | 1 | 2018 | 137 | 0.040 |
Why?
| Age Distribution | 1 | 2017 | 198 | 0.040 |
Why?
| Communication | 1 | 2018 | 273 | 0.030 |
Why?
| Phenotype | 1 | 2018 | 820 | 0.030 |
Why?
| Multiple Organ Failure | 1 | 2015 | 56 | 0.030 |
Why?
| National Institutes of Health (U.S.) | 1 | 2015 | 49 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2018 | 570 | 0.030 |
Why?
| Hematocrit | 1 | 2014 | 51 | 0.030 |
Why?
| Hospital Charges | 1 | 2014 | 50 | 0.030 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 673 | 0.030 |
Why?
| Case Management | 1 | 2013 | 45 | 0.030 |
Why?
| Intention to Treat Analysis | 1 | 2012 | 28 | 0.030 |
Why?
| Prosthesis Design | 1 | 2013 | 262 | 0.030 |
Why?
| Injections, Intravenous | 1 | 2012 | 148 | 0.030 |
Why?
| Centrifugation | 1 | 2011 | 15 | 0.030 |
Why?
| Gastroenteritis | 1 | 2011 | 20 | 0.030 |
Why?
| Ductus Arteriosus | 1 | 2011 | 11 | 0.030 |
Why?
| Central Nervous System | 1 | 2012 | 85 | 0.030 |
Why?
| Ambulances | 1 | 2011 | 7 | 0.030 |
Why?
| Linear Models | 1 | 2012 | 309 | 0.020 |
Why?
| Blood Pressure Monitors | 1 | 2010 | 10 | 0.020 |
Why?
| Hemoglobins | 1 | 2011 | 126 | 0.020 |
Why?
| Blood Pressure Determination | 1 | 2010 | 51 | 0.020 |
Why?
| Single-Blind Method | 1 | 2010 | 120 | 0.020 |
Why?
| Tachyphylaxis | 1 | 2010 | 2 | 0.020 |
Why?
| Receptors, Opioid | 1 | 2010 | 17 | 0.020 |
Why?
| Radiography | 1 | 2011 | 524 | 0.020 |
Why?
| Child Development | 1 | 2012 | 204 | 0.020 |
Why?
| Prealbumin | 1 | 2010 | 24 | 0.020 |
Why?
| Double-Blind Method | 1 | 2012 | 742 | 0.020 |
Why?
| Drug Tolerance | 1 | 2010 | 60 | 0.020 |
Why?
| Cardiology | 1 | 2011 | 105 | 0.020 |
Why?
| Models, Statistical | 1 | 2011 | 259 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2011 | 643 | 0.020 |
Why?
| Nutritional Requirements | 1 | 2010 | 69 | 0.020 |
Why?
| Anesthesia, General | 1 | 2010 | 96 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1476 | 0.020 |
Why?
| Cytokines | 1 | 2012 | 676 | 0.020 |
Why?
| Mice | 3 | 2005 | 6413 | 0.020 |
Why?
| Intraoperative Complications | 1 | 2010 | 125 | 0.020 |
Why?
| Emergency Service, Hospital | 1 | 2011 | 539 | 0.020 |
Why?
| Neurons | 1 | 2010 | 486 | 0.020 |
Why?
| Dietary Supplements | 1 | 2010 | 449 | 0.020 |
Why?
| Chemotaxis | 1 | 2005 | 28 | 0.020 |
Why?
| Superoxides | 1 | 2005 | 61 | 0.020 |
Why?
| DNA Primers | 1 | 2005 | 225 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2012 | 1604 | 0.020 |
Why?
| Blotting, Western | 1 | 2005 | 683 | 0.010 |
Why?
| Animals | 3 | 2005 | 14385 | 0.010 |
Why?
| Pulmonary Surfactant-Associated Protein B | 1 | 2003 | 4 | 0.010 |
Why?
| Cells, Cultured | 1 | 2005 | 1737 | 0.010 |
Why?
| Middle Aged | 1 | 2017 | 13088 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2003 | 1089 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2005 | 1999 | 0.010 |
Why?
|
|
Prodhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Same Department
People who are also in this person's primary department.
|